Shares of personalized health and benefits solutions provider Accolade, Inc. (ACCD) are up more than 17% Friday morning after reporting robust revenue growth in the first quarter.
Revenue for the first quarter increased 44% year-on-year to $85.5 million from $59.5 million.
Net loss, however, widened to $342.82 million or $4.92 per share from $48.71 million or $0.84 per share a year ago, as the company had goodwill impairment charges of 299.71 million in the latest quarter.
Looking forward, the company expects second-quarter revenue to be between $82 million and $83.5 million
For the full year, Accolade has raised the lower end of the revenue outlook, now expecting between $355 million and $365 million from the previous view of $350 million-$365 million.
ACCD, currently at $8.68, has traded in the range of $4.61-$55.47 in the past 52 weeks.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.